Login

4D Pharma hopes to expand drug success to other areas - Duncan Peyton, CEO, 4D Pharma 00:00:00

Share On Facebook Share On Twitter

4D Pharma hopes to expand drug success to other areas

Recent Videos

00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper

Suggestions

00:10:00
Is Long-Term Care Insurance Right for You? Exploring Its Purpose and Benefits | Dr. David Ashby, Co-Founders , Mustard Seed Wealth Management.
00:10:00
Impact of Bank Earnings and Interest Rate Hikes on Wealth Management Strategies
00:10:00
Inflation's Impact on Your Investments – Insights from Jacobson & Schmitt Advisors
00:10:00
long-time early-stage investor currently investing out of their 12th Fund which worth$800M.|Stephen Bloch,General Partner,Canaan Partners
00:10:00
Clara Industries Limited's CEO Nikhil Kukreja Message to Shareholders | Nikhil Kukreja, CEO, Clara Industries Limited.
00:10:00
Ciena CEO Gary Smith discusses the acquisition of Cyan.
00:10:00
Matthew Continetti Reflects on 9/11's Impact and American Conservatism|Matthew Continetti,Professor, American Enterprise Institute
00:10:00
Pete Stavros on KKR’s Expanded Employee Equity Ownership Program
00:10:00
Unveiling the Future: Key Trends in Hedge Fund Strategies for 2024
00:10:00
Discover develop and deliver innovative therapies for the treatment of advanced solid tumors and other major diseases|David J. Mazzo,President,Caladrius Biosciences Inc
00:10:00
Insights on Loyalty Strategies: A Conversation with Eagle Eye NZ's Phil Devlin and CEO Tim Mason |Tim Mason, CEO of Eagle Eye Solutions
00:10:00
Lomiko Metals: Building North America’s Largest Undeveloped Graphite Asset with Non-Dilutive Government Backing|Gordana Slepcev,CEO,Lomiko Metals Inc

© 2017 - Neuhu+